Journal article · 2002 · Open access
Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy
Journal of Neuroscience, 22(18), 7873–7878 · Published 15 September 2002 · DOI 10.1523/jneurosci.22-18-07873.2002
In brief
“Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy” is a 2002 journal article by Brian J. Bacskai and 6 co-authors, published in Journal of Neuroscience. OpenAlex counts 351 citations as of 20 November 2026, which puts it in the top 8% of works published in 2002 by citations. It is open access: the full text is free to read at Journal of Neuroscience.
- Citations
- 351
- Most cited in
- 2020 (8)
- Field-weighted impact
- 8.08
- References
- 25
- Authors
- 7
Abstract
Transgenic (Tg) mouse models overexpressing amyloid precursor protein (APP) develop senile plaques similar to those found in Alzheimer's disease in an age-dependent manner. Recent reports demonstrated that immunotherapy is effective at preventing or removing amyloid-beta deposits in the mouse models. To characterize the mechanisms involved in clearance, we used antibodies of either IgG1 (10d5) or IgG2b (3d6) applied directly to the brains of 18-month-old Tg2576 or 20-month-old PDAPP mice. Both 10d5 and 3d6 led to clearance of 50% of diffuse amyloid deposits in both animal models within 3 d. Fc receptor-mediated clearance has been shown to be important in an ex vivo assay showing antibody-mediated clearance of plaques by microglia. We now show, using in vivo multiphoton microscopy, that FITC-labeled F(ab')2 fragments of 3d6 (which lack the Fc region of the antibody) also led to clearance of 45% of the deposits within 3 d, similar to the results obtained with full-length 3d6 antibody. This result suggests that direct disruption of plaques, in addition to Fc-dependent phagocytosis, is involved in the antibody-mediated clearance of amyloid-beta deposits in vivo. Dense-core deposits that were not cleared were reduced in size by approximately 30% with full-length antibodies and F(ab')2 fragments 3 d after a topical treatment. Together, these results indicate that clearance of amyloid deposits in vivo may involve, in addition to Fc-dependent clearance, a non-Fc-mediated disruption of plaque structure.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2002). Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy. Journal of Neuroscience, 22(18), 7873–7878. https://doi.org/10.1523/jneurosci.22-18-07873.2002
MLA 9
Bacskai, Brian J., et al. “Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy.” Journal of Neuroscience, vol. 22, no. 18, 2002, pp. 7873–7878. https://doi.org/10.1523/jneurosci.22-18-07873.2002.
Chicago
Bacskai, Brian J., Stephen T. Kajdasz, Megan E. McLellan, Dora Games, Peter A. Seubert, Dale Schenk, and Bradley T. Hyman. 2002. “Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy.” Journal of Neuroscience 22 (18): 7873–7878. https://doi.org/10.1523/jneurosci.22-18-07873.2002.
Harvard
Bacskai, B. J. et al. (2002) ‘Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy’, Journal of Neuroscience, 22(18), pp. 7873–7878. doi:10.1523/jneurosci.22-18-07873.2002.
IEEE
B. J. Bacskai et al., “Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy,” Journal of Neuroscience, vol. 22, no. 18, pp. 7873–7878, 2002, doi: 10.1523/jneurosci.22-18-07873.2002.
BibTeX
@article{bacskai2002mediated,
title = {{Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy}},
author = {Bacskai, Brian J. and Kajdasz, Stephen T. and McLellan, Megan E. and Games, Dora and Seubert, Peter A. and Schenk, Dale and Hyman, Bradley T.},
journal = {Journal of Neuroscience},
year = {2002},
volume = {22},
number = {18},
pages = {7873--7878},
doi = {10.1523/jneurosci.22-18-07873.2002},
url = {https://doi.org/10.1523/jneurosci.22-18-07873.2002}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 6 | |
| 2018 | 5 | |
| 2019 | 5 | |
| 2020 | 8 | |
| 2021 | 3 | |
| 2022 | 4 | |
| 2023 | 3 | |
| 2024 | 6 | |
| 2025 | 8 | |
| 2026 | 7 |
Its field-weighted citation impact is 8.08: it has been cited 8.08 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- amyloid-beta clearance
- antibody immunotherapy
- F(ab')2 fragments
- Fc receptors
- Alzheimer's disease
- amyloid plaques
- Tg2576 mice
- PDAPP mice
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2002). Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy. Journal of Neuroscience, 22(18), 7873–7878. https://doi.org/10.1523/jneurosci.22-18-07873.2002
How many times has this paper been cited?
351 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Neuroscience: sign in and open the PDF from this page.
Who wrote this paper?
Brian J. Bacskai, Stephen T. Kajdasz, Megan E. McLellan, Dora Games, Peter A. Seubert, Dale Schenk, Bradley T. Hyman.
What is the DOI of this paper?
10.1523/jneurosci.22-18-07873.2002, permanently at https://doi.org/10.1523/jneurosci.22-18-07873.2002. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.